Nairo Quintana’s Tour de France tramadol disqualification upheld

CAS uphold the UCI decision to disqualify the Colombian after painkiller detected in blood tests

Nairo Quintana
(Image credit: Getty)

The decision to disqualify Nairo Quintana from the 2022 Tour de France by the UCI has been upheld by the Court of Arbitration for Sport [CAS]. 

Quintana returned a positive test during the race for tramadol on two separate occasions.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1

Tom Thewlis